EFSA/ECDC. Avian influenza overview September - November 2025. EFSA Journal. Abstract
submitted by kickingbird at 16 minute(s) ago from EFSA Journal
The magnitude and geographical extent of these detections were unprecedented for this time of the year, particularly in wild birds. Large numbers of waterfowl were affected by the disease, and mass mortality ... Michelle Wille, etc.,al. [preprint]Ecology of low pathogenicity avian influenza virus H7 in wild birds in south-eastern Australia prior to emergence of high pathogenicity avian influenza H7 in poultry. https://doi.org/10.64898/2025.12.08.693062. Abstract
submitted by kickingbird at 2 hours ago from https://doi.org/10.64898/2025.12.08.693062
Adding to the global burden of high pathogenicity avian influenza (HPAI) H5N1, an unprecedented five HPAI H7 outbreaks occurred globally in 2024. Of these, three occurred in southeast Australia, with the ... Sena Mursel, Brian D. Davison, Thomas McAndrew, Bi. Spatiotemporal Dynamics of Avian Influenza: Understanding Avian Influenza Transmission via Mallard Migration Data. Interdisciplinary Perspectives on Infectious Disea. Abstract
submitted by kickingbird at 2 hours ago from Interdisciplinary Perspectives on Infectious Disea
Influenza, categorized as one of the emergent infectious diseases, presents a substantial public health concern due to its capacity to trigger extensive epidemics and global pandemics. Every recent pandemic ... Christopher A Gonelli, etc.,al. Low-level human memory T and B cells recognising avian influenza hemagglutinins are poorly responsive to existing seasonal influenza vaccines. Clinical & Translational Immunology. Abstract
submitted by kickingbird at 2 hours ago from Clinical & Translational Immunology
ObjectivesImmunisation remains the most cost-effective mechanism to combat influenza infection and is widely employed against seasonal influenza viruses. Zoonotic transmission of avian influenza A viruses ... Zhang, L., Shao, Y., Zou, X. et al. A primary oseltamivir-resistant mutation in influenza hemagglutinin and its implications for antiviral resistance surveillance. Nat Commun (2025). Abstract
submitted by kickingbird at 2 hours ago from Nat Commun (2025)
Oseltamivir, a neuraminidase (NA) inhibitor, is currently the most widely used antiviral drug for influenza worldwide. The emergence of primary oseltamivir-resistant mutations in NA protein of seasonally ... | |
- 
